Beam Therapeutics Inc. (BEAM)

NASDAQ: BEAM · Real-Time Price · USD

19.91

-0.02 (-0.10%)

At close: May 01, 2025, 3:59 PM

19.64

-1.34%

After-hours: May 01, 2025, 07:38 PM EDT

Beam Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	63.52M	377.71M	60.92M	51.84M	24K	18K	n/a	n/a
Cost of Revenue	n/a	437.38M	22.58M	16.44M	103.18M	5.41M	650K	11K
Gross Profit	63.52M	-59.67M	38.34M	35.4M	-103.16M	-5.39M	-650K	-11K
Operating Income	-415.57M	-176.49M	-338.48M	-392.46M	-132.76M	-75.15M	-45.74M	-7.88M
Interest Income	n/a	n/a	15.3M	9K	1.57M	2.49M	292K	n/a
Pretax Income	-376.7M	-131.16M	-260.18M	-370.64M	-194.59M	-78.33M	-116.74M	-8M
Net Income	-376.74M	-132.53M	-263.59M	-341.36M	-256.42M	-78.44M	-115.26M	-8M
Selling & General & Admin	111.53M	116.81M	87.81M	57.22M	29.61M	20.55M	11.87M	2.02M
Research & Development	367.56M	437.38M	311.59M	387.09M	103.18M	54.62M	33.87M	5.86M
Other Expenses	n/a	n/a	n/a	n/a	n/a	-71K	-10.04M	378K
Operating Expenses	479.09M	554.19M	399.4M	444.31M	132.78M	75.17M	45.74M	7.88M
Interest Expense	n/a	n/a	15.3M	9K	1.57M	187K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	479.09M	554.19M	399.4M	444.31M	132.78M	75.17M	45.74M	7.88M
Income Tax Expense	39K	1.37M	3.41M	-29.28M	61.83M	116K	-71M	500K
Shares Outstanding (Basic)	82.31M	77.15M	70.02M	64.23M	46.73M	51.34M	35.14M	12.95M
Shares Outstanding (Diluted)	82.31M	77.15M	70.02M	64.23M	46.73M	51.34M	35.14M	12.95M
EPS (Basic)	-4.58	-1.72	-3.76	-5.31	-5.49	-1.53	-3.28	-0.62
EPS (Diluted)	-4.58	-1.72	-3.76	-5.31	-5.49	-1.53	-3.28	-0.62
EBITDA	-415.57M	-156.47M	-324.33M	-392.46M	-128.03M	-71.65M	-45.09M	-7.99M
EBIT	-415.57M	-176.49M	-338.48M	-370.63M	-132.76M	-75.15M	-45.74M	-8M
Depreciation & Amortization	n/a	20.01M	22.58M	16.44M	9.47M	5.41M	650K	11K